Evidence map›Paper›PMID 35784600›Full record

ArticleThe Pan African medical journal2022

Susceptibility status of major malaria vectors to novaluron, an insect growth regulator South-Eastern Tanzania.

Amos Justinian Ngonzi, Letus Laurian Muyaga, Halfan Ngowo, Naomi Urio, John-Mary Vianney, Dickson Wilson Lwetoijera

Open access · goldAbstract read
In one paragraph

Article in The Pan African medical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Amos Justinian NgonziIfakara Health Institute, Environmental Health and Ecological Science Department, PO Box 53, Ifakara, Tanzania.
Letus Laurian MuyagaIfakara Health Institute, Environmental Health and Ecological Science Department, PO Box 53, Ifakara, Tanzania.
Halfan NgowoIfakara Health Institute, Environmental Health and Ecological Science Department, PO Box 53, Ifakara, Tanzania.
Naomi UrioIfakara Health Institute, Environmental Health and Ecological Science Department, PO Box 53, Ifakara, Tanzania.
John-Mary VianneyThe Nelson Mandela African Institution of Science and Technology, Department of Life Science and Bio-Engineering, PO BOX 447, Arusha, Tanzania.
Dickson Wilson LwetoijeraIfakara Health Institute, Environmental Health and Ecological Science Department, PO Box 53, Ifakara, Tanzania.
Ifakara Health Institute · TZNelson Mandela African Institution of Science and Technology · TZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: application of Insect Growth Regulator (IGR) such as pyriproxyfen has shown a promising result in controlling malaria transmitting mosquitoes through autodissemination technique. Novaluron that inhibits the chitin development at mosquito larval stage present a promising candidate IGR for rotation with pyriproxyfen to prevent a chance of resistance development. This study assessed the susceptibility of immature stages of Anopheles arabiensis, Anopheles gambiae and Anopheles funestus to novaluron. Methods: susceptibility bioassays using technical grade novaluron (98% active ingredient) were performed inside the semi-field system using first instar larvae of Anopheles species. For each tested species, a total of 1500 larvae were used in the bioassay. Concentration range of 0.01 mg/l to 2 mg/l of novaluron were tested to establish Lethal Concentration (LC) sufficient to kills 50%, 90% and 99% of the exposed larvae by using log-dose response analysis. Results: of the tested mosquitoes, Anopheles gambiae were highly susceptible to novaluron followed by An. Arabiensis and then An. funestus. Lethal concentrations, LC Conclusion: the study demonstrates the efficacy of novaluron in controlling Anopheles mosquito species at immature stages via larval mortality. These findings warrant further testing of novaluron for autodissemination by different vector species for its inclusion in rotation to prevent development of resistance.

Indexed as

AnophelesMalariaAnimalsHumansJuvenile HormonesLarvaMosquito VectorsPhenylurea CompoundsTanzaniaJuvenile HormonesnovaluronPhenylurea CompoundsAn. arabiensisAn. funestusAn. gambiaeInsect growth regulatornovaluronsusceptibilityTanzania

Identifiers

PMID35784600
PMCPMC9206179
OpenAlexW4226320808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.